ALK reaches a new Japanese milestone
![Foto: ALK, PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article6724379.ece/ALTERNATES/schema-16_9/ALK.jpg)
Japan’s Torii Pharmaceutical gave its Danish partner ALK the perfect Christmas present in the form of submission of an application for ALK’s tablet-based vaccine against Japanese cedar pollen allergy, ALK said in a press release on December 25th.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
ALK CEO eyes higher growth rates - in 2017
For abonnenter
”It’s celebration day out here”
For abonnenter
US sales of pollen drugs continue to disappoint for ALK
For abonnenter